Clinical Core

$1,336,327P30FY2025AGNIH

Stanford University, Stanford CA

Investigators

Linked publications, trials & patents

Paper 39711699 Paper 39677464 Paper 39649607 Paper 39574639 Paper 39554163 Paper 39503843 Paper 39496718 Paper 39496102 Paper 39483910 Paper 39444005 Paper 39428957 Paper 39399688 Paper 39371140 Paper 39365322 Paper 39352226 Paper 39340798 Paper 39314957 Paper 39294787 Paper 39276722 Paper 39217398 Paper 39195563 Paper 39185475 Paper 39149241 Paper 39137265 Paper 39080151 Paper 39077866 Paper 39072037 Paper 39055313 Paper 39011113 Paper 38974877 Paper 38965435 Paper 38962867 Paper 38943387 Paper 38915561 Paper 38903124 Paper 38896163 Paper 38888142 Paper 38883718 Paper 38859733 Paper 38853828 Paper 38788065 Paper 38780681 Paper 38779814 Paper 38768342 Paper 38759012 Paper 38755756 Paper 38753380 Paper 38746455 Paper 38746437 Paper 38712073 Paper 38632391 Paper 38617345 Paper 38612729 Paper 38602280 Paper 38598986 Paper 38585781 Paper 38574399 Paper 38559129 Paper 38539014 Paper 38526701 Paper 38520489 Paper 38507374 Paper 38480892 Paper 38467937 Paper 38464202 Paper 38463500 Paper 38460116 Paper 38436140 Paper 38425134 Paper 38390561 Paper 38380866 Paper 38374692 Paper 38364295 Paper 38355598 Paper 38353367 Paper 38348782 Paper 38348772 Paper 38345347 Paper 38340719 Paper 38312309 Paper 38310122 Paper 38302557 Paper 38301647 Paper 38298163 Paper 38296755 Paper 38267190 Paper 38243325 Paper 38230729 Paper 38222248 Paper 38184787 Paper 38176356 Paper 38146099 Paper 38134931 Paper 38083699 Paper 38057571 Paper 38053483 Paper 38040087 Paper 38034852 Paper 38014176 Paper 38014121

Abstract

SUMMARY CLINICAL CORE The Clinical Core of the Stanford Alzheimerâs Disease Research Center (ADRC) will enroll, assess, and follow participants with Alzheimerâs disease (AD) or Lewy body disease LBD and healthy older adults without cognitive or motor impairment. Participants are characterized by clinical syndrome and by biological disease inferred from fluid and imaging biomarkers. Clinical Core aims are the following: 1) Enroll participants into research protocols of the Stanford ADRC; characterize their neurological, cognitive, and behavioral status; provide consensus diagnoses; provide high-quality clinical data to the Data Management and Statistical Core; follow participants longitudinally; and promote adherence and retention. 2) Support deep phenotyping of ADRC participants in coordination with Imaging, Neuropathology, and Biomarker Cores through clinical assessments, biospecimen collections, and other means. 3) Assess hearing, vision, and olfaction as new Core resources. 4) Support developmental projects and other research needs of investigators interested in AD and AD related dementias. 5) Support the Research and Education Component by providing a rich training environment for students, residents, fellows, and faculty.

View original record on NIH RePORTER →